Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

After-Hours Stock Movers 06/02: Okta Jumps on Beat Qtr; JOANN Sinks on Big Miss

Published 06/02/2022, 01:45 PM
Updated 06/02/2022, 05:47 PM

After-Hours Stock Movers:

StoneCo Ltd (NASDAQ:STNE20% HIGHER; reported Q1 adjusted net income of R$132.2 million. Revenue for the quarter came in at R$2.07 billion,

Joann Inc (NASDAQ:JOAN) 17% LOWER; reported Q1 EPS of ($0.22), $0.32 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $498 million versus the consensus estimate of $516.96 million.

Okta, Inc. (NASDAQ:OKTA) 16% HIGHER; reported Q1 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $415 million versus the consensus estimate of $389.05 million. Okta, Inc. sees Q2 2023 revenue of $428-430 million, versus the consensus of $422.25 million. Okta, Inc. sees FY2023 revenue of $1.805-1.815 million, versus the consensus of $1.78 million.

Zumiez, Inc. (NASDAQ:ZUMZ) 9% LOWER; reported Q1 EPS of ($0.02), $0.09 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $220.7 million versus the consensus estimate of $217.28 million. Zumiez, Inc. sees Q2 2022 EPS of $0.45-$0.55, versus the consensus of $0.68. Zumiez, Inc. sees Q2 2022 revenue of $232-239 million, versus the consensus of $243.7 million.

Kohl's (NYSE:KSS) 8% LOWER; auction delayed indefinitely - NYP

Tilly's, Inc. (NYSE:TLYS) 4% LOWER; reported Q1 EPS of $0.03, $0.01 better than the analyst estimate of $0.02. Revenue for the quarter came in at $145.8 million versus the consensus estimate of $145.79 million. Tilly's, Inc. sees Q2 2022 EPS of $0.14-$0.20, versus the consensus of $0.34. Tilly's, Inc. sees Q2 2022 revenue of $170-175 million, versus the consensus of $18.3 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cooper Companies Inc (NYSE:COO3% LOWER; reported Q2 EPS of $3.24, $0.19 worse than the analyst estimate of $3.43. Revenue for the quarter came in at $829.8 million versus the consensus estimate of $821 million. Cooper Cos. sees FY2022 EPS of $13.09-$13.29, versus the consensus of $13.74. Cooper Cos. sees FY2022 revenue of $3.28-3.312 billion, versus the consensus of $3.29 billion.

Lululemon Athletica Inc (NASDAQ:LULU2% HIGHER; reported Q1 EPS of $1.48, $0.05 better than the analyst estimate of $1.43. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.53 billion. lululemon athletica sees Q2 2022 EPS of $1.82-$1.87, versus the consensus of $1.77. lululemon athletica sees Q2 2022 revenue of $1.75-1.775 billion, versus the consensus of $1.71 billion. lululemon athletica sees FY2022 EPS of $9.35-$9.50, versus the consensus of $9.28. lululemon athletica sees FY2022 revenue of $7.61-7.71 billion, versus the consensus of $7.54 billion.

RH (NYSE:RH) 1% HIGHER; reported Q1 EPS of $7.78, $2.40 better than the analyst estimate of $5.38. Revenue for the quarter came in at $957 million versus the consensus estimate of $924.81 million. Second quarter net revenue in the range of (1%) to (3%), versus up 39% last year, with adjusted operating margin in the range of 23.0% to 23.5%, versus 26.6% a year ago. Fiscal 2022 net revenue growth in the range of 0% to 2%, versus up 32% last year, with adjusted operating margin in the range of 23.0% to 24.0%, versus 25.6% a year ago.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.